CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Long Term Provisions | ₹2.72 Cr | ₹2.53 Cr | ₹2.46 Cr | ₹2.08 Cr |
What is the latest Long Term Provisions ratio of CONCORD DRUGS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.72 Cr |
| Mar2024 | ₹2.53 Cr |
| Mar2023 | ₹2.46 Cr |
| Mar2022 | ₹2.08 Cr |
How is Long Term Provisions of CONCORD DRUGS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.72 Cr | 7.51 | |
| Mar2024 | ₹2.53 Cr | 2.64 | |
| Mar2023 | ₹2.46 Cr | 18.23 | |
| Mar2022 | ₹2.08 Cr | - | |
Compare Long Term Provisions of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹94.0 Cr | -2.4% | -5.5% | 23.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -2.4% |
-5.5% |
23.3% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses